Dextera Surgical Inc.
DXTR
DXTR was delisted on the 12th of December, 2017.
0 hedge funds and large institutions have $0 invested in Dextera Surgical Inc. in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $21K → $0 (-$21K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$18K |
| 2 |
WJA
Williams Jones & Associates
New York
|
-$3K |
DXTR Hedge Fund Activity: Q4 2018 in Review
0 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Dextera Surgical Inc. (DXTR) for Q4 2018, worth a combined $0 — down 100% from $21K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of DXTR and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Primecap Management, exiting entirely with an estimated $18K sold.
- 0 institutional investors held Dextera Surgical Inc. (DXTR) as of Q4 2018, down from 2 in Q3 2018.
- Funds reported $0 of Dextera Surgical Inc. stock for Q4 2018, down 100% quarter-over-quarter.
- 0 funds opened new Dextera Surgical Inc. positions in Q4 2018 and 2 closed out, a net change of -2 holders.
- The largest Dextera Surgical Inc. seller in Q4 2018 was Primecap Management, an estimated $18K sold.
Based on aggregated 13F filings for Q4 2018.